What technical signals does BioSmart (038460) have?

BioSmart current technical signals: no active technical signal.

Is BioSmart a cup-and-handle pattern?

No. BioSmart has no valid cup-and-handle signal right now.

What are BioSmart's financials and valuation?

BioSmart's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

BioSmart

038460 · KOSDAQ

₩2,685+1.51%

2026-09-04 close

BioSmart last closed at ₩2,685 (+1.51%) on 2026-09-04. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…

No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions

303 picks

Next-day win rate

50.7%

Avg next-day

-0.11%

vs market

-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Trade plan

EntryAccount sizeStopTarget (optional)Risk per trade (%)

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

Overall: IT하드웨어 38/211 · top 18%

Factor composite · relative position in sector

PER 552.42 · PBR 0.54 — own-history percentile 20/100 · 100/100

Open self-history band

PER20/100

PBR100/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024

Safe zoneFinancial-metric reference signal

Altman Z'' zoneZ'' 3.33

Distress

Grey

Safe

The marker shows the current Z'' value within the displayed zones.

Altman Z'': 3.33
Beneish M-Score: -2.32
Sloan accrual: -1.40%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

7/9Strong

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score7/9

Profitability

Positive ROAPass
Positive OCFPass
Improving ΔROANot passed
Accruals (OCF > net income)Pass

Leverage & liquidity

Lower debtPass
Higher current ratioPass
No new sharesPass

Efficiency

Higher gross marginNot passed
Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업외손익 급변 (영업이익 대비 66% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

IT하드웨어

This stock is in IT하드웨어: revenue rank 31 of 211, share 0.6%.

31 / 2110.6%revenue share

Who dominates this industry?

1LG이노텍24.4%
2삼성전기11.8%
3삼지전자3.9%
4에스에이엠티3.3%
5영풍3.2%
6바이오스마트0.6%

Concentration

DistributedCR3 40.1%

HHI 813211 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedDivergent lenses

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p: 6.82
Direction: 축소
Level: 좁음
Years: 7

Value lens

P90/P10: 10.9
Median P/B: 0.97
Level: 넓음
n: 193

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin: 2.8%
Interest coverage: 3x
Return on equity (ROE): 0.1%

Operating margin −5pp

Operating loss

Interest coverageBase 3x-2.3x

Return on equity (ROE)Base 0.1%-11.7%

Revenue −15%

Tolerable

Interest coverageBase 3x2.5x

Return on equity (ROE)Base 0.1%5.4%

Interest rate +2pp

Tolerable

Interest coverageBase 3x1.9x

Return on equity (ROE)Base 0.1%4.9%

Interest coverage limit

Current margin 1.9pp

Interest coverage limit at an operating margin of 1%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-19

Suppliers disclosed by the company in its 2026-03-19 annual report.

Suppliers without disclosed amount

PVCTAPEROLLHOLOGRAMPCSSCROFCRODHALEIAIWLEADCABLE+6 more

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

박혜린26.55%2026-08-12 · 증감 +0.59%p

Connections

AI-extracted related companies · for reference

Suppliers

삼성전자Price comovement r=0.13 (1 year)SK하이닉스Price comovement r=0.19 (1 year)

Customers

NHN KCPPrice comovement r=0.11 (1 year)한화시스템Price comovement r=0.05 (1 year)현대모비스Price comovement r=0.11 (1 year)LG CNSPrice comovement r=0.02 (1 year)롯데정보통신삼성SDS

Competitors

한국정보통신Price comovement r=0.11 (1 year)다날Price comovement r=0.10 (1 year)KG이니시스Price comovement r=0.25 (1 year)코리아써키트Price comovement r=0.13 (1 year)

Same theme

RFID전자결제

🔗 See in the full market map →

Recent filings

BioSmart's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About BioSmart

What technical signals does BioSmart (038460) have?: BioSmart current technical signals: no active technical signal.
Is BioSmart a cup-and-handle pattern?: No. BioSmart has no valid cup-and-handle signal right now.
What are BioSmart's financials and valuation?: BioSmart's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy